Results 1-8 of 8 (Search time: 0.002 seconds).
Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link | |
---|---|---|---|---|---|---|---|
1 | 2022 | Bispecific T-cell engagers non-covalently decorated drug-loaded PEGylated nanocarriers for cancer immunochemotherapy | Cheng, WJ; Chuang, KH; Lo, YJ; Chen, M; Chen, YJ; Roffler, SR ; Ho, HO; Lin, SY; Sheu, MT | Journal of Controlled Release 344, 235-248 | |||
2 | 2022 | Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pancreatic Cancer Treatment | Lin, HJ; Liang, TL; Chang, YY; Liu, DZ; Fan, JY; Roffler, SR ; Lin, SY | Pharmaceutics 14(6), 1202 | |||
3 | 2022 | Glucuronides: From biological waste to bio-nanomedical applications | Burnouf, PA; Roffler, SR ; Wu, CC; Su, YC | Journal of controlled release : official journal of the Controlled Release Society 349, 765-782 | |||
4 | 2022 | In Vivo Hematopoietic Stem Cell Gene Therapy for SARS-CoV2 Infection Using a Decoy Receptor | Wang, H; Li, C; Obadan, AO; Frizzell, H; Hsiang, TY; Gil, S; Germond, A; Fountain, C; Baldessari, A; Roffler, S ; Kiem, HP; Fuller, DH; Lieber, A | Human gene therapy 33(7-8), 389-403 | |||
5 | 2022 | Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis | Cheng, KW; Tseng, CH; Chen, IJ; Huang, BC; Liu, HJ; Ho, KW; Lin, WW; Chuang, CH; Huang, MY; Leu, YL; Roffler, SR ; Wang, JY; Chen, YL; Cheng, TL | Pharmacological research 177, 106115 | |||
6 | 2022 | Structural determination of an antibody that specifically recognizes polyethylene glycol with a terminal methoxy group | Nguyen, MT; Shih, YC; Lin, MH; Roffler, SR ; Hsiao, CY; Cheng, TL; Lin, WW; Lin, EC; Jong, YJ; Chang, CY; Su, YC | Communications chemistry 5(1), 88 | |||
7 | 2022 | The interplay between membrane topology and mechanical forces in regulating T cell receptor activity | Al-Aghbar, MA; Jainarayanan, AK; Dustin, ML; Roffler, SR | Communications biology 5(1), 40 | |||
8 | 2022 | Translational development of a tumor junction opening technology | Kim, J; Li, C; Wang, H; Kaviraj, S; Singh, S; Savergave, L; Raghuwanshi, A; Gil, S; Germond, A; Baldessari, A; Chen, B; Roffler, S ; Fender, P; Drescher, C; Carter, D; Lieber, A | Scientific reports 12(1), 7753 |